Five Massachusetts Hospitals Sue Eli Lilly Over Discounts
The hospitals allege the drugmaker withheld tens of millions in 340B discounts after they declined to share patient data.
Updated on Nov. 4, 2026 in Healthcare
Live Poll
Do you trust drug companies to run discount programs for patients without demanding their data?
Five Massachusetts hospitals have sued Eli Lilly in U.S. District Court in Boston, alleging the drugmaker violated the 340B drug discount program. The suit claims Lilly refused to provide tens of millions of dollars in discounts because the hospitals declined to share privacy-protected patient data.
Why it matters
The dispute centers on how hospitals can access federally mandated drug discounts without surrendering sensitive patient information to manufacturers. Lilly says the data is needed to prevent hospitals from double-dipping discounts across the 340B and Medicaid programs. The hospitals warn that if the practice is not halted, other drug companies may take similar action.
The complaint alleges tens of millions of dollars in discounts were withheld from the five hospitals, which include Massachusetts General, Brigham and Women's, Salem, UMass Memorial Medical Center and UMass Memorial Health - Harrington. The total owed and the court's ruling on the claims remain unresolved.
The players
Eli Lilly
Indianapolis-based pharmaceutical company that operates a $700 million research center in Boston and reached a trillion-dollar market capitalization.
Massachusetts General Hospital
Boston teaching hospital affiliated with Harvard Medical School and one of the five hospitals suing Lilly.
Brigham and Women's Hospital
Boston hospital affiliated with Harvard Medical School and one of the five plaintiffs in the suit against Lilly.
UMass Memorial Health
Worcester-based health system whose UMass Memorial Medical Center and Harrington affiliate are among the plaintiffs.
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire academic medical center that has filed a separate lawsuit against Lilly over similar data requests.
The details
Lilly allegedly required hospitals to submit claims data through a third-party platform owned by a private equity firm before granting discounts. When the hospitals declined to share privacy-protected patient data, Lilly withheld the discounts, prompting the lawsuit. Dartmouth-Hitchcock Medical Center and Tampa General Hospital have filed similar suits against the company.
Timeline
The lawsuit was filed recently in U.S. District Court in Boston.
Other hospitals filed similar lawsuits against Lilly in recent months.
Market Landscape
The suit fits a broader pattern of drugmakers contesting how the 340B Drug Pricing Program is administered, with several hospitals now pursuing parallel claims against Lilly. Its outcome could shape whether manufacturers can impose data-sharing conditions on the discounts that Congress created for safety-net providers.
Hospitals that receive 340B discounts may see changes in drug costs depending on how the lawsuits are resolved. Patients served by these hospitals could be affected if discount availability shifts.
The takeaway
The outcome of these suits may determine whether drugmakers can require patient data in exchange for federally mandated discounts. Readers following healthcare costs should watch how the court treats the data-sharing condition.
Further reading
For more on the policy behind these disputes, explore Healthcare coverage on Wisevoter.
Source note: This article includes information reported by Boston.
Live Poll
Do you trust drug companies to run discount programs for patients without demanding their data?
